Industry Presentations



  • NON

    Hear from an expert in the treatment of ALK+ metastatic NSCLC

    Speakers:Eric Bernicker, MD

    Duration: 25 minutes

    Presented on: April 24, 2020

    *This session is not eligible for AMA PRA Category 1 CreditsTM


  • Eric Bernicker, MD

    Eric Bernicker, MD

    Eric Bernicker, MD

    Dr. Bernicker earned his medical degree from Baylor College of Medicine in Houston, TX in 1990. Subsequently, he completed his residency at Baylor Affiliated Hospitals and was chief medical resident at Ben Taub General Hospital from 1993–1994. Dr. Bernicker held a faculty appointment at Baylor College of Medicine as a clinical assistant professor from 1996–2012 before joining the Houston Methodist Cancer Center in January 2013, where he serves as director of Medical Thoracic Oncology. As a physician-scientist, Dr. Bernicker oversees the expansion of clinical trials at The Methodist Hospital relating to Thoracic Oncology with all stages of disease, a combination of SWOG trials, and industry trials of novel targeted agents.